Wells Fargo & Company MN lessened its position in shares of Clorox Co (NYSE:CLX) by 1.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,303,296 shares of the company’s stock after selling 53,003 shares during the quarter. Wells Fargo & Company MN’s holdings in Clorox were worth $640,071,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of CLX. APG Asset Management N.V. grew its stake in Clorox by 38.6% during the 4th quarter. APG Asset Management N.V. now owns 1,804,215 shares of the company’s stock valued at $223,483,000 after purchasing an additional 502,300 shares during the last quarter. Acadian Asset Management LLC grew its stake in Clorox by 33.9% during the 4th quarter. Acadian Asset Management LLC now owns 1,049,445 shares of the company’s stock valued at $156,092,000 after purchasing an additional 265,892 shares during the last quarter. Nuance Investments LLC grew its stake in Clorox by 909.1% during the 4th quarter. Nuance Investments LLC now owns 247,386 shares of the company’s stock valued at $36,796,000 after purchasing an additional 222,871 shares during the last quarter. JPMorgan Chase & Co. grew its stake in Clorox by 63.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 417,347 shares of the company’s stock valued at $54,269,000 after purchasing an additional 161,555 shares during the last quarter. Finally, Retirement Systems of Alabama grew its stake in Clorox by 172.9% during the 3rd quarter. Retirement Systems of Alabama now owns 170,419 shares of the company’s stock valued at $22,480,000 after purchasing an additional 107,972 shares during the last quarter. Institutional investors and hedge funds own 73.42% of the company’s stock.

CLX has been the topic of several research analyst reports. Zacks Investment Research upgraded Clorox from a “hold” rating to a “buy” rating and set a $163.00 price target on the stock in a research note on Monday, January 8th. BMO Capital Markets set a $147.00 price target on Clorox and gave the company a “buy” rating in a research note on Monday, February 5th. Morgan Stanley dropped their price target on Clorox from $138.00 to $128.00 and set an “equal weight” rating on the stock in a research note on Thursday, November 2nd. Jefferies Group reiterated a “hold” rating and set a $132.00 price target on shares of Clorox in a research note on Wednesday, November 1st. Finally, Wells Fargo & Co reiterated a “hold” rating and set a $130.00 price target on shares of Clorox in a research note on Wednesday, December 13th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $132.46.

In other news, SVP Michael R. Costello sold 10,574 shares of the business’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total value of $1,438,169.74. Following the completion of the transaction, the senior vice president now owns 34,867 shares of the company’s stock, valued at approximately $4,742,260.67. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.00% of the company’s stock.

Clorox Co (NYSE:CLX) opened at $128.39 on Wednesday. The stock has a market capitalization of $16,630.00, a PE ratio of 21.17, a PEG ratio of 2.40 and a beta of 0.31. The company has a quick ratio of 0.86, a current ratio of 1.22 and a debt-to-equity ratio of 2.35. Clorox Co has a fifty-two week low of $124.09 and a fifty-two week high of $150.40.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Friday, February 2nd. The company reported $1.23 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.22 by $0.01. The business had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Clorox had a return on equity of 126.70% and a net margin of 13.21%. The company’s revenue for the quarter was up .7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.14 EPS. sell-side analysts expect that Clorox Co will post 6.23 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Clorox Co (CLX) Shares Sold by Wells Fargo & Company MN” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this news story can be viewed at https://www.thecerbatgem.com/2018/02/14/clorox-co-clx-shares-sold-by-wells-fargo-company-mn.html.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.